Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug;67(8):1384-1385.
doi: 10.4103/ijo.IJO_430_19.

Ophthalmic biosimilars: Lessons from India

Ashish Sharma  1 , Nilesh Kumar  1 , Baruch D Kuppermann  2 , Bandello Francesco  3 , Anat Lowenstein  4
Affiliations

Ophthalmic biosimilars: Lessons from India

Ashish Sharma et al. Indian J Ophthalmol. 2019 Aug.

Erratum in

No abstract available

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest

References

    1. Sharma A, Reddy P, Kuppermann BD, Bandello F, Loewenstein A. Biosimilars in ophthalmology: Is there a big change on the horizon? Clin Ophthalmol. 2018;12:2137–43. - PMC - PubMed
    1. [Last cited on 2019 Mar 03]. Available from: https://www.moneycontrol.com/news/business/companies/exclusive-complaint... .
    1. Souied EH, Dugel PU, Ferreira A, Hashmonay R, Lu J, Kelly SP. Severe ocular inflammation following ranibizumab or aflibercept injections for age-related macular degeneration: A retrospective claims database analysis. Ophthalmic Epidemiol. 2016;23:71–9. - PMC - PubMed
    1. Sharma A, Kumar N, Kuppermann BD, Francesco B, Loewenstein A. Biotherapeutics and immunogenicity: ophthalmic perspective. Eye. 2019 Apr 09; - PMC - PubMed

MeSH terms